Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
2601
2602
2603
2604
2605
2606
2607
2608
2609
2610
2611
2612
2613
2614
2615
2616
2617
2618
2619
2620
2621
2622
2623
2624
2625
2626
2627
2628
2629
2630
2631
2632
2633
2634
2635
2636
2637
2638
2639
2640
2641
2642
2643
2644
2645
2646
2647
2648
2649
2650
2651
2652
2653
2654
2655
2656
2657
2658
2659
2660
2661
2662
2663
2664
2665
2666
2667
2668
2669
2670
2671
2672
2673
2674
2675
2676
2677
2678
2679
2680
2681
2682
2683
2684
2685
2686
2687
2688
2689
2690
2691
2692
2693
2694
2695
2696
2697
2698
2699
2700
2701
2702
2703
2704
2705
2706
2707
2708
2709
2710
2711
2712
2713
2714
2715
2716
2717
2718
2719
2720
2721
2722
2723
2724
2725
2726
2727
2728
2729
2730
2731
2732
2733
2734
2735
2736
2737
2738
2739
2740
2741
2742
2743
2744
2745
2746
2747
2748
2749
2750
2751
2752
2753
2754
2755
2756
2757
2758
2759
2760
2761
2762
2763
2764
2765
2766
2767
2768
2769
2770
2771
2772
2773
2774
2775
2776
2777
2778
2779
2780
2781
2782
2783
2784
2785
2786
2787
2788
2789
2790
2791
2792
2793
2794
2795
2796
2797
2798
2799
2800
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF07679 | Immunoglobulin I-set domain | 418 | 501 | 5.7E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF07679 | Immunoglobulin I-set domain | 894 | 975 | 1.2E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF07679 | Immunoglobulin I-set domain | 246 | 319 | 4.8E-7 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF07679 | Immunoglobulin I-set domain | 328 | 413 | 3.0E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF07679 | Immunoglobulin I-set domain | 519 | 594 | 3.1E-11 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF07679 | Immunoglobulin I-set domain | 603 | 688 | 2.9E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF00041 | Fibronectin type III domain | 1079 | 1160 | 3.6E-13 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF00041 | Fibronectin type III domain | 696 | 777 | 2.6E-15 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF00041 | Fibronectin type III domain | 1278 | 1361 | 3.9E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF00041 | Fibronectin type III domain | 984 | 1062 | 4.4E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2913|m.1413 | UnnamedSample_HQ_transcript/2913 | Identity 0.707 too low. | 37e6e14acb413870418a72587b4586de | 1440 | Pfam | PF00041 | Fibronectin type III domain | 1178 | 1260 | 7.7E-13 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/18895|m.6550 | UnnamedSample_HQ_transcript/18895 | Coverage 0.829 too low. | 2bf6e6ddf15206fb7918b267f4280595 | 368 | Pfam | PF00096 | Zinc finger, C2H2 type | 279 | 301 | 3.5E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/94914|m.21945 | UnnamedSample_HQ_transcript/94914 | Identity 0.883 too low. | 57678ffe51ea609a949d510433a720e1 | 154 | Pfam | PF12895 | Anaphase-promoting complex, cyclosome, subunit 3 | 26 | 104 | 2.2E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/25756|m.8411 | UnnamedSample_HQ_transcript/25756 | Coverage 0.541 too low. | be956d038ff6913ba65ea9b6cea4804d | 884 | Pfam | PF00439 | Bromodomain | 353 | 433 | 3.4E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/35811|m.10885 | UnnamedSample_HQ_transcript/35811 | Coverage 0.368 too low. | 8adc2f13a68c6da7a3c7016070b31845 | 151 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 4 | 142 | 3.6E-53 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/29403|m.9328 | UnnamedSample_HQ_transcript/29403 | Coverage 0.742 too low. | a488632eb5b57f743cb19fee1ac5d0d7 | 732 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 641 | 708 | 1.5E-29 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/101454|m.22811 | UnnamedSample_HQ_transcript/101454 | Coverage 0.222 too low. | 2b3de1de73425ac129efa2b14c6adce4 | 309 | Pfam | PF13522 | Glutamine amidotransferase domain | 78 | 193 | 1.1E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/105782|m.23316 | UnnamedSample_HQ_transcript/105782 | Coverage 0.248 too low. | 2b3de1de73425ac129efa2b14c6adce4 | 309 | Pfam | PF13522 | Glutamine amidotransferase domain | 78 | 193 | 1.1E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/52248|m.14496 | UnnamedSample_HQ_transcript/52248 | Coverage 0.746 too low. | 4a42094277c689ab3d763640b3e070fb | 493 | Pfam | PF00664 | ABC transporter transmembrane region | 4 | 198 | 3.5E-37 | T | 22-09-2020 | IPR011527 | ABC transporter type 1, transmembrane domain |
| UnnamedSample_HQ_transcript/52248|m.14496 | UnnamedSample_HQ_transcript/52248 | Coverage 0.746 too low. | 4a42094277c689ab3d763640b3e070fb | 493 | Pfam | PF00005 | ABC transporter | 271 | 419 | 2.5E-26 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/3221|m.1532 | UnnamedSample_HQ_transcript/3221 | Coverage 0.249 too low. | a3739c6e2c32dea8ada7e2fc80f48e74 | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 6.9E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/51448|m.14341 | UnnamedSample_HQ_transcript/51448 | Coverage 0.474 too low. | 5982a468b3fd350a93387447b13b5c14 | 224 | Pfam | PF01851 | Proteasome/cyclosome repeat | 127 | 159 | 1.6E-4 | T | 22-09-2020 | IPR002015 | Proteasome/cyclosome repeat |
| UnnamedSample_HQ_transcript/51448|m.14341 | UnnamedSample_HQ_transcript/51448 | Coverage 0.474 too low. | 5982a468b3fd350a93387447b13b5c14 | 224 | Pfam | PF01851 | Proteasome/cyclosome repeat | 92 | 124 | 3.2E-4 | T | 22-09-2020 | IPR002015 | Proteasome/cyclosome repeat |
| UnnamedSample_HQ_transcript/68420|m.17653 | UnnamedSample_HQ_transcript/68420 | Coverage 0.143 too low. | 71deaa9e2ccd368153806faf7e98e8f2 | 440 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 94 | 362 | 4.3E-52 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/14145|m.5150 | UnnamedSample_HQ_transcript/14145 | Unmapped. | 2ba3d08ef82222bc16b55f6987d5b9d7 | 737 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 712 | 1.6E-8 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/56249|m.15291 | UnnamedSample_HQ_transcript/56249 | Coverage 0.716 too low. | 91388c9fb913e3048a33d6e25b2aef52 | 488 | Pfam | PF00554 | Rel homology DNA-binding domain | 174 | 333 | 3.0E-28 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/56249|m.15291 | UnnamedSample_HQ_transcript/56249 | Coverage 0.716 too low. | 91388c9fb913e3048a33d6e25b2aef52 | 488 | Pfam | PF16179 | Rel homology dimerisation domain | 341 | 432 | 7.6E-25 | T | 22-09-2020 | IPR032397 | Rel homology dimerisation domain |
| UnnamedSample_HQ_transcript/63272|m.16684 | UnnamedSample_HQ_transcript/63272 | Coverage 0.767 too low. | 91388c9fb913e3048a33d6e25b2aef52 | 488 | Pfam | PF00554 | Rel homology DNA-binding domain | 174 | 333 | 3.0E-28 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/63272|m.16684 | UnnamedSample_HQ_transcript/63272 | Coverage 0.767 too low. | 91388c9fb913e3048a33d6e25b2aef52 | 488 | Pfam | PF16179 | Rel homology dimerisation domain | 341 | 432 | 7.6E-25 | T | 22-09-2020 | IPR032397 | Rel homology dimerisation domain |
| UnnamedSample_HQ_transcript/82474|m.20105 | UnnamedSample_HQ_transcript/82474 | Coverage 0.982 too low. | 47eff377a978095a8898f46988ba288e | 446 | Pfam | PF00249 | Myb-like DNA-binding domain | 292 | 333 | 1.2E-6 | T | 22-09-2020 | IPR001005 | SANT/Myb domain |
| UnnamedSample_HQ_transcript/4648|m.2051 | UnnamedSample_HQ_transcript/4648 | Coverage 0.831 too low. | c2194df0ada3b78ba4fd4e3c796d92f2 | 636 | Pfam | PF00554 | Rel homology DNA-binding domain | 180 | 339 | 5.0E-28 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/4648|m.2051 | UnnamedSample_HQ_transcript/4648 | Coverage 0.831 too low. | c2194df0ada3b78ba4fd4e3c796d92f2 | 636 | Pfam | PF16179 | Rel homology dimerisation domain | 347 | 438 | 1.2E-24 | T | 22-09-2020 | IPR032397 | Rel homology dimerisation domain |
| UnnamedSample_HQ_transcript/8942|m.3496 | UnnamedSample_HQ_transcript/8942 | Coverage 0.031 too low. | b09242346dc2e0c5afb1bdadb94c54b4 | 1078 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 6 | 61 | 7.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8942|m.3496 | UnnamedSample_HQ_transcript/8942 | Coverage 0.031 too low. | b09242346dc2e0c5afb1bdadb94c54b4 | 1078 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 903 | 960 | 4.5E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8942|m.3496 | UnnamedSample_HQ_transcript/8942 | Coverage 0.031 too low. | b09242346dc2e0c5afb1bdadb94c54b4 | 1078 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 327 | 381 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8942|m.3496 | UnnamedSample_HQ_transcript/8942 | Coverage 0.031 too low. | b09242346dc2e0c5afb1bdadb94c54b4 | 1078 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 72 | 122 | 2.8E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8942|m.3496 | UnnamedSample_HQ_transcript/8942 | Coverage 0.031 too low. | b09242346dc2e0c5afb1bdadb94c54b4 | 1078 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 258 | 312 | 5.2E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8942|m.3496 | UnnamedSample_HQ_transcript/8942 | Coverage 0.031 too low. | b09242346dc2e0c5afb1bdadb94c54b4 | 1078 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 532 | 585 | 1.4E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8942|m.3496 | UnnamedSample_HQ_transcript/8942 | Coverage 0.031 too low. | b09242346dc2e0c5afb1bdadb94c54b4 | 1078 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 836 | 891 | 1.7E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8942|m.3496 | UnnamedSample_HQ_transcript/8942 | Coverage 0.031 too low. | b09242346dc2e0c5afb1bdadb94c54b4 | 1078 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 773 | 829 | 3.5E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6969|m.2849 | UnnamedSample_HQ_transcript/6969 | Coverage 0.120 too low. | 4e8a16a3d5076fb6f7453667929c0d7b | 1293 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 44 | 174 | 1.3E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6969|m.2849 | UnnamedSample_HQ_transcript/6969 | Coverage 0.120 too low. | 4e8a16a3d5076fb6f7453667929c0d7b | 1293 | Pfam | PF00098 | Zinc knuckle | 195 | 212 | 2.0E-4 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/6969|m.2849 | UnnamedSample_HQ_transcript/6969 | Coverage 0.120 too low. | 4e8a16a3d5076fb6f7453667929c0d7b | 1293 | Pfam | PF00098 | Zinc knuckle | 270 | 285 | 0.0013 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/6969|m.2849 | UnnamedSample_HQ_transcript/6969 | Coverage 0.120 too low. | 4e8a16a3d5076fb6f7453667929c0d7b | 1293 | Pfam | PF07727 | Reverse transcriptase (RNA-dependent DNA polymerase) | 819 | 1053 | 1.5E-43 | T | 22-09-2020 | IPR013103 | Reverse transcriptase, RNA-dependent DNA polymerase |
| UnnamedSample_HQ_transcript/34704|m.10654 | UnnamedSample_HQ_transcript/34704 | Coverage 0.595 too low. | a3a7f8053538870b46f5e21476af70fe | 517 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 104 | 351 | 1.0E-44 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/18485|m.6442 | UnnamedSample_HQ_transcript/18485 | Coverage 0.083 too low. | 868236fcd1905f19bc6d9e1890f84bbc | 975 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 23 | 92 | 5.9E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/18485|m.6442 | UnnamedSample_HQ_transcript/18485 | Coverage 0.083 too low. | 868236fcd1905f19bc6d9e1890f84bbc | 975 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 193 | 367 | 3.9E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/116234|m.24513 | UnnamedSample_HQ_transcript/116234 | Coverage 0.914 too low. | a78e8025af330c732eb52a4c0cb31556 | 217 | Pfam | PF12874 | Zinc-finger of C2H2 type | 124 | 143 | 0.032 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/116234|m.24513 | UnnamedSample_HQ_transcript/116234 | Coverage 0.914 too low. | a78e8025af330c732eb52a4c0cb31556 | 217 | Pfam | PF00096 | Zinc finger, C2H2 type | 6 | 26 | 2.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/116234|m.24513 | UnnamedSample_HQ_transcript/116234 | Coverage 0.914 too low. | a78e8025af330c732eb52a4c0cb31556 | 217 | Pfam | PF00096 | Zinc finger, C2H2 type | 86 | 109 | 0.0029 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/49240|m.13863 | UnnamedSample_HQ_transcript/49240 | Coverage 0.782 too low. | eea898aa842536d3311ab2f8dfe9996c | 440 | Pfam | PF03015 | Male sterility protein | 295 | 388 | 5.0E-23 | T | 22-09-2020 | IPR033640 | Fatty acyl-CoA reductase, C-terminal |
| UnnamedSample_HQ_transcript/49240|m.13863 | UnnamedSample_HQ_transcript/49240 | Coverage 0.782 too low. | eea898aa842536d3311ab2f8dfe9996c | 440 | Pfam | PF07993 | Male sterility protein | 5 | 222 | 8.4E-49 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/14288|m.5192 | UnnamedSample_HQ_transcript/14288 | Coverage 0.270 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 341 | 472 | 8.1E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/14288|m.5192 | UnnamedSample_HQ_transcript/14288 | Coverage 0.270 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF01661 | Macro domain | 67 | 180 | 1.1E-23 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/68515|m.17669 | UnnamedSample_HQ_transcript/68515 | Coverage 0.556 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 341 | 472 | 8.1E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/68515|m.17669 | UnnamedSample_HQ_transcript/68515 | Coverage 0.556 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF01661 | Macro domain | 67 | 180 | 1.1E-23 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/57056|m.15459 | UnnamedSample_HQ_transcript/57056 | Coverage 0.507 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 341 | 472 | 8.1E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/57056|m.15459 | UnnamedSample_HQ_transcript/57056 | Coverage 0.507 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF01661 | Macro domain | 67 | 180 | 1.1E-23 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/51794|m.14406 | UnnamedSample_HQ_transcript/51794 | Coverage 0.471 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 341 | 472 | 8.1E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/51794|m.14406 | UnnamedSample_HQ_transcript/51794 | Coverage 0.471 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF01661 | Macro domain | 67 | 180 | 1.1E-23 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/64760|m.16990 | UnnamedSample_HQ_transcript/64760 | Coverage 0.529 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 341 | 472 | 8.1E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/64760|m.16990 | UnnamedSample_HQ_transcript/64760 | Coverage 0.529 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF01661 | Macro domain | 67 | 180 | 1.1E-23 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/30941|m.9695 | UnnamedSample_HQ_transcript/30941 | Coverage 0.357 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 341 | 472 | 8.1E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/30941|m.9695 | UnnamedSample_HQ_transcript/30941 | Coverage 0.357 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF01661 | Macro domain | 67 | 180 | 1.1E-23 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/56792|m.15403 | UnnamedSample_HQ_transcript/56792 | Coverage 0.480 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 341 | 472 | 8.1E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/56792|m.15403 | UnnamedSample_HQ_transcript/56792 | Coverage 0.480 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF01661 | Macro domain | 67 | 180 | 1.1E-23 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/50427|m.14110 | UnnamedSample_HQ_transcript/50427 | Coverage 0.450 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 341 | 472 | 8.1E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/50427|m.14110 | UnnamedSample_HQ_transcript/50427 | Coverage 0.450 too low. | fe2f572b2a46083115ed8b6d2c931f66 | 489 | Pfam | PF01661 | Macro domain | 67 | 180 | 1.1E-23 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/5071|m.2224 | UnnamedSample_HQ_transcript/5071 | Coverage 0.737 too low. | 3032abd876a9e96a3d076971cce93e26 | 1070 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 442 | 703 | 1.8E-91 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/5071|m.2224 | UnnamedSample_HQ_transcript/5071 | Coverage 0.737 too low. | 3032abd876a9e96a3d076971cce93e26 | 1070 | Pfam | PF03623 | Focal adhesion targeting region | 890 | 1021 | 2.6E-56 | T | 22-09-2020 | IPR005189 | Focal adhesion kinase, targeting (FAT) domain |
| UnnamedSample_HQ_transcript/5071|m.2224 | UnnamedSample_HQ_transcript/5071 | Coverage 0.737 too low. | 3032abd876a9e96a3d076971cce93e26 | 1070 | Pfam | PF18038 | FERM N-terminal domain | 84 | 164 | 2.3E-18 | T | 22-09-2020 | IPR041390 | Focal adhesion kinase, N-terminal |
| UnnamedSample_HQ_transcript/5071|m.2224 | UnnamedSample_HQ_transcript/5071 | Coverage 0.737 too low. | 3032abd876a9e96a3d076971cce93e26 | 1070 | Pfam | PF00373 | FERM central domain | 173 | 293 | 7.8E-6 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/9121|m.3551 | UnnamedSample_HQ_transcript/9121 | Coverage 0.951 too low. | 3032abd876a9e96a3d076971cce93e26 | 1070 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 442 | 703 | 1.8E-91 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/9121|m.3551 | UnnamedSample_HQ_transcript/9121 | Coverage 0.951 too low. | 3032abd876a9e96a3d076971cce93e26 | 1070 | Pfam | PF03623 | Focal adhesion targeting region | 890 | 1021 | 2.6E-56 | T | 22-09-2020 | IPR005189 | Focal adhesion kinase, targeting (FAT) domain |
| UnnamedSample_HQ_transcript/9121|m.3551 | UnnamedSample_HQ_transcript/9121 | Coverage 0.951 too low. | 3032abd876a9e96a3d076971cce93e26 | 1070 | Pfam | PF18038 | FERM N-terminal domain | 84 | 164 | 2.3E-18 | T | 22-09-2020 | IPR041390 | Focal adhesion kinase, N-terminal |
| UnnamedSample_HQ_transcript/9121|m.3551 | UnnamedSample_HQ_transcript/9121 | Coverage 0.951 too low. | 3032abd876a9e96a3d076971cce93e26 | 1070 | Pfam | PF00373 | FERM central domain | 173 | 293 | 7.8E-6 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/113953|m.24293 | UnnamedSample_HQ_transcript/113953 | Unmapped. | dab7097e7352bbb09d6cc3b7dbeab08e | 184 | Pfam | PF00186 | Dihydrofolate reductase | 4 | 181 | 1.2E-40 | T | 22-09-2020 | IPR001796 | Dihydrofolate reductase domain |
| UnnamedSample_HQ_transcript/108754|m.23677 | UnnamedSample_HQ_transcript/108754 | Unmapped. | dab7097e7352bbb09d6cc3b7dbeab08e | 184 | Pfam | PF00186 | Dihydrofolate reductase | 4 | 181 | 1.2E-40 | T | 22-09-2020 | IPR001796 | Dihydrofolate reductase domain |
| UnnamedSample_HQ_transcript/45546|m.13047 | UnnamedSample_HQ_transcript/45546 | Coverage 0.979 too low. | 0320840f8e1ed5b9694cfb0a8fe05519 | 514 | Pfam | PF00373 | FERM central domain | 216 | 324 | 3.0E-22 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/45546|m.13047 | UnnamedSample_HQ_transcript/45546 | Coverage 0.979 too low. | 0320840f8e1ed5b9694cfb0a8fe05519 | 514 | Pfam | PF16511 | N-terminal or F0 domain of Talin-head FERM | 4 | 85 | 5.6E-33 | T | 22-09-2020 | IPR032425 | Talin, N-terminal F0 domain |
| UnnamedSample_HQ_transcript/45546|m.13047 | UnnamedSample_HQ_transcript/45546 | Coverage 0.979 too low. | 0320840f8e1ed5b9694cfb0a8fe05519 | 514 | Pfam | PF02174 | PTB domain (IRS-1 type) | 340 | 408 | 7.4E-6 | T | 22-09-2020 | IPR002404 | IRS-type PTB domain |
| UnnamedSample_HQ_transcript/12483|m.4656 | UnnamedSample_HQ_transcript/12483 | Identity 0.910 too low. | b1df9bcb2c9409faa25528adca4b8ba0 | 1261 | Pfam | PF02172 | KIX domain | 461 | 490 | 7.5E-6 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/12483|m.4656 | UnnamedSample_HQ_transcript/12483 | Identity 0.910 too low. | b1df9bcb2c9409faa25528adca4b8ba0 | 1261 | Pfam | PF02172 | KIX domain | 526 | 571 | 1.6E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/12483|m.4656 | UnnamedSample_HQ_transcript/12483 | Identity 0.910 too low. | b1df9bcb2c9409faa25528adca4b8ba0 | 1261 | Pfam | PF02135 | TAZ zinc finger | 105 | 182 | 4.0E-20 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/12483|m.4656 | UnnamedSample_HQ_transcript/12483 | Identity 0.910 too low. | b1df9bcb2c9409faa25528adca4b8ba0 | 1261 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 1107 | 1146 | 2.6E-23 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/12483|m.4656 | UnnamedSample_HQ_transcript/12483 | Identity 0.910 too low. | b1df9bcb2c9409faa25528adca4b8ba0 | 1261 | Pfam | PF00439 | Bromodomain | 1013 | 1095 | 3.5E-18 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/28390|m.9067 | UnnamedSample_HQ_transcript/28390 | Unmapped. | f28152c7d34838d2f78b090f1a5d6d55 | 961 | Pfam | PF00910 | RNA helicase | 475 | 583 | 3.0E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/10310|m.3925 | UnnamedSample_HQ_transcript/10310 | Coverage 0.705 too low. | e8547c1bc8cea13a282598bda37b3052 | 586 | Pfam | PF01483 | Proprotein convertase P-domain | 60 | 148 | 2.3E-25 | T | 22-09-2020 | IPR002884 | P domain |
| UnnamedSample_HQ_transcript/10310|m.3925 | UnnamedSample_HQ_transcript/10310 | Coverage 0.705 too low. | e8547c1bc8cea13a282598bda37b3052 | 586 | Pfam | PF14843 | Growth factor receptor domain IV | 247 | 355 | 1.0E-14 | T | 22-09-2020 | IPR032778 | Growth factor receptor domain 4 |
| UnnamedSample_HQ_transcript/97032|m.22235 | UnnamedSample_HQ_transcript/97032 | Coverage 0.989 too low. | 9a8608d80d3023b717aefea1cd5b6982 | 189 | Pfam | PF00012 | Hsp70 protein | 1 | 165 | 9.3E-44 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/3012|m.1447 | UnnamedSample_HQ_transcript/3012 | Unmapped. | 31155f308044cd239bcb3e95d5af3e76 | 1085 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 860 | 1.3E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/110132|m.23855 | UnnamedSample_HQ_transcript/110132 | Coverage 0.683 too low. | 93edcd1dbb634bc7c99348690e3332b6 | 276 | Pfam | PF00168 | C2 domain | 169 | 265 | 6.1E-22 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/46907|m.13344 | UnnamedSample_HQ_transcript/46907 | Unmapped. | 61588a1e57454ef62006dfe240e72aaa | 492 | Pfam | PF17831 | Pyruvate dehydrogenase E1 component middle domain | 93 | 305 | 5.4E-106 | T | 22-09-2020 | IPR041621 | Pyruvate dehydrogenase E1 component, middle domain |
| UnnamedSample_HQ_transcript/87238|m.20830 | UnnamedSample_HQ_transcript/87238 | Coverage 0.529 too low. | a306a23c993fee07d7cc0934831b3f8d | 366 | Pfam | PF13424 | Tetratricopeptide repeat | 230 | 297 | 8.6E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/76241|m.19068 | UnnamedSample_HQ_transcript/76241 | Coverage 0.603 too low. | a306a23c993fee07d7cc0934831b3f8d | 366 | Pfam | PF13424 | Tetratricopeptide repeat | 230 | 297 | 8.6E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/26427|m.8583 | UnnamedSample_HQ_transcript/26427 | Coverage 0.109 too low. | 39b77c11afcb7b5ee46e9b7913114441 | 980 | Pfam | PF00651 | BTB/POZ domain | 558 | 661 | 2.2E-15 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/26427|m.8583 | UnnamedSample_HQ_transcript/26427 | Coverage 0.109 too low. | 39b77c11afcb7b5ee46e9b7913114441 | 980 | Pfam | PF00651 | BTB/POZ domain | 416 | 476 | 1.8E-9 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/26427|m.8583 | UnnamedSample_HQ_transcript/26427 | Coverage 0.109 too low. | 39b77c11afcb7b5ee46e9b7913114441 | 980 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 13 | 73 | 1.7E-7 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/26427|m.8583 | UnnamedSample_HQ_transcript/26427 | Coverage 0.109 too low. | 39b77c11afcb7b5ee46e9b7913114441 | 980 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 76 | 126 | 1.6E-6 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/17287|m.6088 | UnnamedSample_HQ_transcript/17287 | Coverage 0.354 too low. | 425ebc173d6c7904650f1f4e5c494b20 | 808 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 622 | 676 | 8.7E-12 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/119848|m.24834 | UnnamedSample_HQ_transcript/119848 | Coverage 0.975 too low. | 00956a78161faaa1b99f834ede4c60e8 | 188 | Pfam | PF17135 | Ribosomal protein 60S L18 and 50S L18e | 2 | 188 | 3.2E-89 | T | 22-09-2020 | IPR021131 | Ribosomal protein L18e/L15P |
| UnnamedSample_HQ_transcript/39139|m.11670 | UnnamedSample_HQ_transcript/39139 | Coverage 0.947 too low. | c8d99eb8034f91b5fd1ceb7c54bc689f | 731 | Pfam | PF00890 | FAD binding domain | 97 | 128 | 8.2E-6 | T | 22-09-2020 | IPR003953 | FAD-dependent oxidoreductase 2, FAD binding domain |
| UnnamedSample_HQ_transcript/39139|m.11670 | UnnamedSample_HQ_transcript/39139 | Coverage 0.947 too low. | c8d99eb8034f91b5fd1ceb7c54bc689f | 731 | Pfam | PF00307 | Calponin homology (CH) domain | 532 | 634 | 8.0E-16 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/3885|m.1768 | UnnamedSample_HQ_transcript/3885 | Identity 0.801 too low. | eb3d3b91a6fb6202e1ec3dae78111528 | 1383 | Pfam | PF01171 | PP-loop family | 1125 | 1291 | 2.3E-12 | T | 22-09-2020 | IPR011063 | tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal |
| UnnamedSample_HQ_transcript/3885|m.1768 | UnnamedSample_HQ_transcript/3885 | Identity 0.801 too low. | eb3d3b91a6fb6202e1ec3dae78111528 | 1383 | Pfam | PF00266 | Aminotransferase class-V | 67 | 435 | 6.5E-26 | T | 22-09-2020 | IPR000192 | Aminotransferase class V domain |
| UnnamedSample_HQ_transcript/85019|m.20504 | UnnamedSample_HQ_transcript/85019 | Coverage 0.800 too low. | 1ef7034ed76c79bc696e6859a5194066 | 456 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 48 | 108 | 1.1E-25 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/8656|m.3396 | UnnamedSample_HQ_transcript/8656 | Coverage 0.088 too low. | 1d509deeb7869be114abde48358fdc72 | 1065 | Pfam | PF00400 | WD domain, G-beta repeat | 384 | 454 | 0.24 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/8656|m.3396 | UnnamedSample_HQ_transcript/8656 | Coverage 0.088 too low. | 1d509deeb7869be114abde48358fdc72 | 1065 | Pfam | PF08366 | LLGL2 | 280 | 373 | 5.1E-30 | T | 22-09-2020 | IPR013577 | Lethal giant larvae homologue 2 |
| UnnamedSample_HQ_transcript/47405|m.13447 | UnnamedSample_HQ_transcript/47405 | Identity 0.938 too low. | b6e7db3206b09bd82238899aec83c3c9 | 408 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 36 | 406 | 2.9E-78 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/58664|m.15787 | UnnamedSample_HQ_transcript/58664 | Coverage 0.979 too low. | c87f8ebd0a8ab37b494075b41e87fede | 621 | Pfam | PF01142 | tRNA pseudouridine synthase D (TruD) | 192 | 588 | 4.6E-69 | T | 22-09-2020 | IPR001656 | Pseudouridine synthase, TruD |
| UnnamedSample_HQ_transcript/33646|m.10374 | UnnamedSample_HQ_transcript/33646 | Coverage 0.339 too low. | 375a112b13c687a6958b77987ef85f71 | 435 | Pfam | PF00501 | AMP-binding enzyme | 1 | 301 | 1.3E-69 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/41023|m.12067 | UnnamedSample_HQ_transcript/41023 | Coverage 0.402 too low. | 375a112b13c687a6958b77987ef85f71 | 435 | Pfam | PF00501 | AMP-binding enzyme | 1 | 301 | 1.3E-69 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/86636|m.20746 | UnnamedSample_HQ_transcript/86636 | Coverage 0.617 too low. | 375a112b13c687a6958b77987ef85f71 | 435 | Pfam | PF00501 | AMP-binding enzyme | 1 | 301 | 1.3E-69 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/53105|m.14660 | UnnamedSample_HQ_transcript/53105 | Identity 0.548 too low. | e8f1a59faa8db7f115d26d5141f4fdeb | 656 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 5.6E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/53105|m.14660 | UnnamedSample_HQ_transcript/53105 | Identity 0.548 too low. | e8f1a59faa8db7f115d26d5141f4fdeb | 656 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 1.8E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/53105|m.14660 | UnnamedSample_HQ_transcript/53105 | Identity 0.548 too low. | e8f1a59faa8db7f115d26d5141f4fdeb | 656 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.1E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/53105|m.14660 | UnnamedSample_HQ_transcript/53105 | Identity 0.548 too low. | e8f1a59faa8db7f115d26d5141f4fdeb | 656 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.3E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/53105|m.14660 | UnnamedSample_HQ_transcript/53105 | Identity 0.548 too low. | e8f1a59faa8db7f115d26d5141f4fdeb | 656 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 2.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/53105|m.14660 | UnnamedSample_HQ_transcript/53105 | Identity 0.548 too low. | e8f1a59faa8db7f115d26d5141f4fdeb | 656 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 8.0E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/97222|m.22268 | UnnamedSample_HQ_transcript/97222 | Unmapped. | 2517f0c77cce04958025f922ac276acc | 295 | Pfam | PF00140 | Sigma-70 factor, region 1.2 | 99 | 129 | 1.0E-12 | T | 22-09-2020 | IPR009042 | RNA polymerase sigma-70 region 1.2 |
| UnnamedSample_HQ_transcript/97222|m.22268 | UnnamedSample_HQ_transcript/97222 | Unmapped. | 2517f0c77cce04958025f922ac276acc | 295 | Pfam | PF04546 | Sigma-70, non-essential region | 142 | 295 | 9.7E-45 | T | 22-09-2020 | IPR007631 | RNA polymerase sigma factor 70, non-essential domain |
| UnnamedSample_HQ_transcript/97222|m.22268 | UnnamedSample_HQ_transcript/97222 | Unmapped. | 2517f0c77cce04958025f922ac276acc | 295 | Pfam | PF03979 | Sigma-70 factor, region 1.1 | 4 | 79 | 2.1E-30 | T | 22-09-2020 | IPR007127 | RNA polymerase sigma factor 70, region 1.1 |
| UnnamedSample_HQ_transcript/34259|m.10533 | UnnamedSample_HQ_transcript/34259 | Coverage 0.835 too low. | 1fa7770cd2d3e48c2b61e1118d022ade | 860 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 2.0E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/34259|m.10533 | UnnamedSample_HQ_transcript/34259 | Coverage 0.835 too low. | 1fa7770cd2d3e48c2b61e1118d022ade | 860 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 766 | 1.0E-284 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/4775|m.2102 | UnnamedSample_HQ_transcript/4775 | Coverage 0.275 too low. | d826d2d7916f6a9e7af4f526cf7427e3 | 1559 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 1263 | 1558 | 1.9E-58 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/4775|m.2102 | UnnamedSample_HQ_transcript/4775 | Coverage 0.275 too low. | d826d2d7916f6a9e7af4f526cf7427e3 | 1559 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 1159 | 1216 | 2.5E-22 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/118974|m.24774 | UnnamedSample_HQ_transcript/118974 | Coverage 0.785 too low. | a1e32377edfdf05b676e2fb6e2d08320 | 152 | Pfam | PF03870 | RNA polymerase Rpb8 | 7 | 149 | 4.8E-53 | T | 22-09-2020 | IPR005570 | RNA polymerase, Rpb8 |
| UnnamedSample_HQ_transcript/53113|m.14664 | UnnamedSample_HQ_transcript/53113 | Identity 0.611 too low. | c31be5c03375559d221cdac09cdc656b | 645 | Pfam | PF19055 | ABC-2 type transporter | 260 | 319 | 1.5E-6 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/53113|m.14664 | UnnamedSample_HQ_transcript/53113 | Identity 0.611 too low. | c31be5c03375559d221cdac09cdc656b | 645 | Pfam | PF00005 | ABC transporter | 74 | 229 | 2.8E-22 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/53113|m.14664 | UnnamedSample_HQ_transcript/53113 | Identity 0.611 too low. | c31be5c03375559d221cdac09cdc656b | 645 | Pfam | PF01061 | ABC-2 type transporter | 376 | 584 | 6.3E-27 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/24599|m.8104 | UnnamedSample_HQ_transcript/24599 | Coverage 0.327 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 392 | 467 | 3.6E-17 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/24599|m.8104 | UnnamedSample_HQ_transcript/24599 | Coverage 0.327 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 158 | 233 | 4.7E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/24599|m.8104 | UnnamedSample_HQ_transcript/24599 | Coverage 0.327 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 32 | 105 | 6.3E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/24599|m.8104 | UnnamedSample_HQ_transcript/24599 | Coverage 0.327 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 291 | 368 | 2.3E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/24599|m.8104 | UnnamedSample_HQ_transcript/24599 | Coverage 0.327 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 495 | 573 | 4.8E-11 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/10857|m.4099 | UnnamedSample_HQ_transcript/10857 | Coverage 0.253 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 392 | 467 | 3.6E-17 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/10857|m.4099 | UnnamedSample_HQ_transcript/10857 | Coverage 0.253 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 158 | 233 | 4.7E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/10857|m.4099 | UnnamedSample_HQ_transcript/10857 | Coverage 0.253 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 32 | 105 | 6.3E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/10857|m.4099 | UnnamedSample_HQ_transcript/10857 | Coverage 0.253 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 291 | 368 | 2.3E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/10857|m.4099 | UnnamedSample_HQ_transcript/10857 | Coverage 0.253 too low. | 7594383cbc4978df0287a3d16d74a34e | 574 | Pfam | PF00595 | PDZ domain | 495 | 573 | 4.8E-11 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/49572|m.13924 | UnnamedSample_HQ_transcript/49572 | Coverage 0.924 too low. | 240ccd8028916033615ef46bc3e8ce64 | 392 | Pfam | PF01699 | Sodium/calcium exchanger protein | 2 | 112 | 2.2E-16 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/49572|m.13924 | UnnamedSample_HQ_transcript/49572 | Coverage 0.924 too low. | 240ccd8028916033615ef46bc3e8ce64 | 392 | Pfam | PF01699 | Sodium/calcium exchanger protein | 226 | 375 | 9.1E-32 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/65910|m.17189 | UnnamedSample_HQ_transcript/65910 | Coverage 0.984 too low. | c244de68fe3ff8e2811368e8d22e88d8 | 263 | Pfam | PF16776 | Type II inositol 1,4,5-trisphosphate 5-phosphatase PH domain | 21 | 155 | 1.0E-22 | T | 22-09-2020 | IPR031896 | INPP5B, PH domain |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF00041 | Fibronectin type III domain | 1257 | 1338 | 2.9E-15 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 508 | 601 | 1.2E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 609 | 695 | 2.8E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 807 | 880 | 5.3E-7 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 889 | 974 | 3.4E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 1356 | 1442 | 2.1E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 1164 | 1249 | 3.2E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 1080 | 1155 | 4.2E-11 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 706 | 795 | 3.6E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 1456 | 1536 | 1.3E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 979 | 1062 | 6.4E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF07679 | Immunoglobulin I-set domain | 383 | 473 | 8.6E-23 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/4398|m.1956 | UnnamedSample_HQ_transcript/4398 | Coverage 0.662 too low. | 08a90ed5b008da3e776359ba25f98fd1 | 1576 | Pfam | PF14604 | Variant SH3 domain | 302 | 347 | 6.8E-8 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/67943|m.17569 | UnnamedSample_HQ_transcript/67943 | Coverage 0.932 too low. | ea17bf82f487f16a350a01f498cf7d16 | 547 | Pfam | PF04825 | N terminus of Rad21 / Rec8 like protein | 1 | 103 | 2.7E-40 | T | 22-09-2020 | IPR006910 | Rad21/Rec8-like protein, N-terminal |
| UnnamedSample_HQ_transcript/88136|m.20956 | UnnamedSample_HQ_transcript/88136 | Coverage 0.979 too low. | 501a5193574c408215ffbdece0f60dee | 370 | Pfam | PF03366 | YEATS family | 28 | 108 | 1.2E-24 | T | 22-09-2020 | IPR005033 | YEATS |
| UnnamedSample_HQ_transcript/93520|m.21737 | UnnamedSample_HQ_transcript/93520 | Coverage 0.980 too low. | 501a5193574c408215ffbdece0f60dee | 370 | Pfam | PF03366 | YEATS family | 28 | 108 | 1.2E-24 | T | 22-09-2020 | IPR005033 | YEATS |
| UnnamedSample_HQ_transcript/31135|m.9745 | UnnamedSample_HQ_transcript/31135 | Identity 0.836 too low. | e0a92ec9085f2e308d66e72b18209897 | 871 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 574 | 870 | 5.7E-60 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/31135|m.9745 | UnnamedSample_HQ_transcript/31135 | Identity 0.836 too low. | e0a92ec9085f2e308d66e72b18209897 | 871 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 471 | 528 | 1.3E-22 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/111415|m.24012 | UnnamedSample_HQ_transcript/111415 | Coverage 0.903 too low. | 40fd8babcf6eddd334824c2f8942da21 | 206 | Pfam | PF00012 | Hsp70 protein | 1 | 164 | 8.6E-45 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 299 | 343 | 2.1E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 733 | 781 | 4.7E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 346 | 396 | 4.8E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 788 | 839 | 6.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 678 | 723 | 3.6E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 594 | 614 | 0.0095 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 842 | 887 | 1.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 629 | 675 | 2.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 243 | 290 | 1.5E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 182 | 230 | 6.4E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 890 | 933 | 5.1E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00052 | Laminin B (Domain IV) | 462 | 593 | 9.0E-27 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/15693|m.5612 | UnnamedSample_HQ_transcript/15693 | Coverage 0.943 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 2 | 179 | 2.4E-52 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 299 | 343 | 2.1E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 733 | 781 | 4.7E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 346 | 396 | 4.8E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 788 | 839 | 6.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 678 | 723 | 3.6E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 594 | 614 | 0.0095 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 842 | 887 | 1.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 629 | 675 | 2.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 243 | 290 | 1.5E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 182 | 230 | 6.4E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00053 | Laminin EGF domain | 890 | 933 | 5.1E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00052 | Laminin B (Domain IV) | 462 | 593 | 9.0E-27 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/17799|m.6244 | UnnamedSample_HQ_transcript/17799 | Coverage 0.969 too low. | a09a3a583a708191595bbb19ae783e4d | 1134 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 2 | 179 | 2.4E-52 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/75052|m.18854 | UnnamedSample_HQ_transcript/75052 | Coverage 0.304 too low. | 0fb468956363e0501cf32fff0db56c02 | 285 | Pfam | PF09820 | Predicted AAA-ATPase | 44 | 103 | 5.6E-10 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/57208|m.15488 | UnnamedSample_HQ_transcript/57208 | Coverage 0.131 too low. | 1cdcc7270e8ee646ffb9213fc78547bf | 337 | Pfam | PF16493 | N-terminal of Homeobox Meis and PKNOX1 | 109 | 193 | 4.1E-44 | T | 22-09-2020 | IPR032453 | Homeobox protein PKNOX/Meis, N-terminal |
| UnnamedSample_HQ_transcript/36861|m.11134 | UnnamedSample_HQ_transcript/36861 | Coverage 0.229 too low. | 459cbb780d062bcbcbcdb3811ea91d94 | 236 | Pfam | PF00089 | Trypsin | 28 | 216 | 1.4E-35 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/44628|m.12837 | UnnamedSample_HQ_transcript/44628 | Coverage 0.274 too low. | a3dbcde486e981d674cc99d4afd4ae5e | 256 | Pfam | PF09814 | HECT-like Ubiquitin-conjugating enzyme (E2)-binding | 16 | 231 | 2.6E-7 | T | 22-09-2020 | IPR019193 | Ubiquitin-conjugating enzyme E2-binding protein |
| UnnamedSample_HQ_transcript/49052|m.13811 | UnnamedSample_HQ_transcript/49052 | Coverage 0.370 too low. | 615ce5bbd347d92f49b8d1ebc7774cbd | 381 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 148 | 240 | 3.5E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/20038|m.6882 | UnnamedSample_HQ_transcript/20038 | Coverage 0.876 too low. | 640755c1297eb6e7c42de4e8f5b130c3 | 864 | Pfam | PF00209 | Sodium:neurotransmitter symporter family | 237 | 726 | 1.3E-44 | T | 22-09-2020 | IPR000175 | Sodium:neurotransmitter symporter |
| UnnamedSample_HQ_transcript/23536|m.7812 | UnnamedSample_HQ_transcript/23536 | Coverage 0.945 too low. | 640755c1297eb6e7c42de4e8f5b130c3 | 864 | Pfam | PF00209 | Sodium:neurotransmitter symporter family | 237 | 726 | 1.3E-44 | T | 22-09-2020 | IPR000175 | Sodium:neurotransmitter symporter |
| UnnamedSample_HQ_transcript/9119|m.3550 | UnnamedSample_HQ_transcript/9119 | Coverage 0.950 too low. | 640755c1297eb6e7c42de4e8f5b130c3 | 864 | Pfam | PF00209 | Sodium:neurotransmitter symporter family | 237 | 726 | 1.3E-44 | T | 22-09-2020 | IPR000175 | Sodium:neurotransmitter symporter |
| UnnamedSample_HQ_transcript/20462|m.6993 | UnnamedSample_HQ_transcript/20462 | Coverage 0.909 too low. | 640755c1297eb6e7c42de4e8f5b130c3 | 864 | Pfam | PF00209 | Sodium:neurotransmitter symporter family | 237 | 726 | 1.3E-44 | T | 22-09-2020 | IPR000175 | Sodium:neurotransmitter symporter |
| UnnamedSample_HQ_transcript/56372|m.15314 | UnnamedSample_HQ_transcript/56372 | Coverage 0.554 too low. | df38ac85a65ee191aaf287cf64b72521 | 398 | Pfam | PF02174 | PTB domain (IRS-1 type) | 123 | 202 | 4.0E-11 | T | 22-09-2020 | IPR002404 | IRS-type PTB domain |
| UnnamedSample_HQ_transcript/49686|m.13955 | UnnamedSample_HQ_transcript/49686 | Identity 0.629 too low. | 0aa5bf24540e2c3849070e582a8e411d | 366 | Pfam | PF13639 | Ring finger domain | 174 | 217 | 2.2E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/49686|m.13955 | UnnamedSample_HQ_transcript/49686 | Identity 0.629 too low. | 0aa5bf24540e2c3849070e582a8e411d | 366 | Pfam | PF02225 | PA domain | 9 | 89 | 3.8E-7 | T | 22-09-2020 | IPR003137 | PA domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
